News

Month/Year

29

2024-03

Deciphering Genetic Testing for Hereditary Cancer Diagnosis | BGI Insight

What is hereditary cancer?Hereditary cancer is caused by germline mutations, typically following an inheritance pattern within a family. In contrast, ...

Deciphering Genetic Testing for Hereditary Cancer Diagnosis | BGI Insight

13

2024-03

Advancing Healthcare in Uzbekistan: BGI Genomics CEO's Vision Shared on Uzbekistan's National Television

Zhao Lijian, CEO of BGI Genomics, being interviewed by Uzbekistan's National TelevisionZhao Lijian, CEO of BGI Genomics, provided fresh insights on ...

Advancing Healthcare in Uzbekistan: BGI Genomics CEO's Vision Shared on Uzbekistan's National Television

06

2024-03

From China to Uzbekistan - United for Women’s Wellness on IWD

- Interviewing Wang Leilei, the first blind model in China, and Viktoriya Tsay, head of the department of prenatal and Neonatal Medicine at Genscreen,...

From China to Uzbekistan - United for Women’s Wellness on IWD

04

2024-03

Enhancing High-risk Infant Outcomes with Newborn Genetic Screening in China

Newborn genetic screening (NBGS) is a critical component of early neonatal care, designed to detect genetic disorders that can affect a child's long-t...

Enhancing High-risk Infant Outcomes with Newborn Genetic Screening in China

19

2024-02

NIFTY® DNBSEQ-G99 Platform Achieves CE-IVDD Certification - Enhancing Prenatal Care Options

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY® non-invasive prenatal testing kit and software (CE-IVDD List B) were g...

NIFTY® DNBSEQ-G99 Platform Achieves CE-IVDD Certification - Enhancing Prenatal Care Options
No More

TOP